KEY TAKEAWAY: Janssen’s campaign for their AFIB drug Xarelto is a good one. The banner appeared in the NY Times health section which in turn leads to an in depth article on AFIB with an ad for Xarelto in the sidebar.
KEY TAKEAWAY: The US market for major depressive disorders will rise from $2.4 billion in 2015 to $4.6 billion in 2025. Rexulti, I believe, is doing a great job trying to reach new patients with a great creative TV spot. Continue reading
KEY TAKEAWAY:According to PBS.org surprisingly, huge numbers of cancer patients lack basic information, such as how long they can expect to live, whether their condition is curable or why they’re being prescribed chemotherapy or radiation, said Dr. Rab Razzak, director of outpatient palliative medicine at Johns Hopkins Medicine in Baltimore. The result: People with advanced cancer don’t know enough about their disease to make informed decisions about treatment or how they want to spend their remaining time. But is the new DTC for Oncology products, adding to the confusion? Continue reading
KEY TAKEAWAY: DTC TV ads can produce results, but it’s essential to drive patients into the doctor to ask for your drug while educating physicians on the telltale symptoms of the disease state you are marketing to. Continue reading
KEY TAKEAWAY: DTC ads should light the fuse for information seeking by your target audience. That information, more and more, is going online for more information and finding out about side effects, cost and what others are saying about your drug. If you fail to keep the fuse lit you risk a dud instead of a DTC explosion. Continue reading
KEY TAKEAWAY: The DTC marketing environment is changing before our very eyes, but unless organizations can acknowledge and adapt to the changes the ROI on DTC marketing will continue to decline. Continue reading
KEY TAKEAWAY: It has always been believed the objective of DTC marketing is to drive patients into the doctor to ask for your product but can DTC advertising still work in an era when insurers have a lot of power and patients face hurdles to getting an Rx? Continue reading